Camel Tobacco Detail
Opponents of tobacco harm reduction have portrayed that public health strategy as a marginal approach to smoking cessation that is neither legitimate nor credible. Finally, that specious position may be convincingly undermined, by no less an authority than the National Cancer Institute. The NCI is funding a study, based at the Medical University of South Carolina, that will evaluate the impact of Camel Snus in a nationwide randomized clinical trial among 1,250 smokers who are not motivated to quit.
The trial will run for one year, although the grant is active until 2016 (description here); the NCI has provided over $400,000 for the current fiscal year. The research is being directed by Matthew Carpenter, a psychiatrist at MUSC who previously published a pilot study demonstrating that Ariva and Stonewall dissolvable tobacco products are effective cigarette substitutes (described in this blog last January, here).
Opponents of tobacco harm reduction have portrayed that public health strategy as a marginal approach to smoking cessation that is neither legitimate nor credible. Finally, that specious position may be convincingly undermined, by no less an authority than the National Cancer Institute. The NCI is funding a study, based at the Medical University of South Carolina, that will evaluate the impact of Camel Snus in a nationwide randomized clinical trial among 1,250 smokers who are not motivated to quit.
The trial will run for one year, although the grant is active until 2016 (description here); the NCI has provided over $400,000 for the current fiscal year. The research is being directed by Matthew Carpenter, a psychiatrist at MUSC who previously published a pilot study demonstrating that Ariva and Stonewall dissolvable tobacco products are effective cigarette substitutes (described in this blog last January, here).
Camel Tobacco
Camel Tobacco
Camel Tobacco
Camel Tobacco
Camel Tobacco
Camel Tobacco
Camel Tobacco
Camel Tobacco
Camel Tobacco
Camel Tobacco
Camel Tobacco
Camel Tobacco
No comments:
Post a Comment